Skip to content

H2020HORIZONFP7

Abbvie Inc

Country
USUnited States
Defence projects
0
Projects, all programmes
29
As coordinator
0
EU contribution (CORDIS)
EUR 0
Active
2011 to 2025

Projects

29 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
READIResearch in Europe and Diversity InclusionHORIZON2025ParticipantEUR 0
VICT3RDeveloping and implementing VIrtual Control groups To reducE animal use in toxicology ResearchHORIZON2024ParticipantEUR 0
Project-COMFORTPatient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)HORIZON2024ParticipantEUR 0
GUIDE.MRDGUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRDHORIZON2023ParticipantEUR 0
FACILITATEFrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystemH20202022ParticipantEUR 0
RealHOPEReal World Handling of Protein Drugs - Exploration, Evaluation and EducationH20202021ParticipantEUR 0
OPTIMAOptimal treatment for patients with solid tumours in Europe through Artificial intelligenceH20202021ParticipantEUR 0
HIPPOCRATESHealth Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European StatesH20202021ParticipantEUR 0
SISAQOL-IMIEstablishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trialsH20202021ParticipantEUR 0
PharmaLedgerPharmaLedgerH20202020ParticipantEUR 0
HARMONY PLUSHEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUSH20202020ParticipantEUR 0
H2OH2O Health Outcomes ObservatoryH20202020ParticipantEUR 0
CARECorona Accelerated R&D in EuropeH20202020ParticipantEUR 0
IDEA-FASTIdentifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseasesH20202019ParticipantEUR 0
EU-PEARLEU Patient- cEntric clinicAl tRial pLatformH20202019ParticipantEUR 0
ConcePTIONBuilding an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generationH20202019ParticipantEUR 0
Trials@HomeTrials@Home: Center of Excellence – Remote Decentralised Clinical TrialsH20202019ParticipantEUR 0
IMMUcanIntegrated IMMUnoprofiling of large adaptive CANcer patients cohortsH20202019ParticipantEUR 0
ArthritisHealEstablishing the molecular fundamentals of arthritic diseases – a step forward to Heal ArthritisH20202019PartnerEUR 0
EFOEUPATIEnsuring the future of EUPATI beyond 2020H20202018ParticipantEUR 0

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.